PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data-Reference-Cited by-同舟云学术

PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data

Published:2020-11-03 Issue:4 Volume:47 Page:516-521
ISSN:1076-0512
Container-title:Dermatologic Surgery
language:en
Short-container-title:DS

Author:

Taylor Susan C.,Grimes Pearl E.,Joseph John H.,Jonker Anneke,Avelar Rui L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Surgery

Reference10 articles.

1. Aesthetic considerations in female skin of color: what you need to know;Henry;Semin Cutan Med Surg,2018

2. Ethnic and gender considerations in the use of facial injectables: African-American patients;Burgess;Plast Reconstr Surg,2015

3. Aging differences in ethnic skin;Vashi;J Clin Aesthet Dermatol,2016

4. Myths and knowledge gaps in the aesthetic treatment of patients with skin of color;Alexis;J Drugs Dermatol,2019

5. Understanding the female African American facial aesthetic patient;Alexis;J Drugs Dermatol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cosmetic Considerations in Dark-Skinned Patients;Clinical, Cosmetic and Investigational Dermatology;2024-02

2. PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study data;Journal of Cosmetic Dermatology;2023-04-27

3. Aesthetic considerations when treating patients of African descent: Thriving in diversity international roundtable series;Journal of Cosmetic Dermatology;2023-03-10

4. Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials;Aesthetic Surgery Journal;2022-09-10

5. An update on cosmetic procedures in people of color. Part 2: Neuromodulators, soft tissue augmentation, chemexfoliating agents, and laser hair reduction;Journal of the American Academy of Dermatology;2022-04